Chiou-Ying Yang

Chiou-Ying Yang

orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 August 2014 in Small
Verified
Journal Article
Closed access
PDF file
HLHsing‐Ying Lin
Hsing‐Ying Lin
CHChen‐Han Huang
Chen‐Han Huang
WHWen‐Hsin Hsieh
Wen‐Hsin Hsieh
LLLing‐Hsuan Liu
Ling‐Hsuan Liu
YLYuan‐Chuen Lin
Yuan‐Chuen Lin
CYChiou-Ying Yang
Chiou-Ying Yang

4 April 2006 in Biotechnology and Bioengineering
Verified
Journal Article
Closed access
PDF file
FWFinn C. Wiberg
Finn C. Wiberg
SRSøren K. Rasmussen
Søren K. Rasmussen
TFTorben P. Frandsen
Torben P. Frandsen
LRLone K. Rasmussen
Lone K. Rasmussen
KTKaja Tengbjerg
Kaja Tengbjerg
ATAnne B. Tolstrup
Anne B. Tolstrup

15 August 2012 in Journal of Virology
Verified
Journal Article
Closed access
CLCheng-Hung Luo
Cheng-Hung Luo
PCPei-Yu Chiou
Pei-Yu Chiou
CYChiou-Ying Yang
Chiou-Ying Yang
NLNien Tsung Lin
Nien Tsung Lin
Helicobacter pyloriis a common human pathogen that has been identified to be carcinogenic. This study isolated the temperate bacteriophage 1961P from the lysate of a clinical strain ofH. pyloriisolated in Taiwan. The bacteriophage has an icosahedral head and a short tail, typical of thePodoviridaefamily. Its double-stranded DNA genome is 26,836 bp long and has 33 open reading frames. Only 9 of the predicted proteins have homologs of known functions, while the remaining 24 are only similar to unknown proteins encoded byHelicobacterprophages and remnants. Analysis of sequences proximal to the phage-host junctions suggests that 1961P may integrate into the host chromosome via a mechanism similar to that of bacteriophage lambda. In addition, 1961P is capable of generalized transduction. To the best of our knowledge, this is the first report of the isolation, characterization, genome analysis, integration, and transduction of aHelicobacter pyloriphage.

16 May 2013 in Molecular Biology Reports
Verified
Journal Article
Open access
PDF file
WCWen-Yu Cheng
Wen-Yu Cheng
MCMing-Tsang Chiao
Ming-Tsang Chiao
YLYea-Jiuen Liang
Yea-Jiuen Liang
YYYi-Chin Yang
Yi-Chin Yang
CSChiung-Chyi Shen
Chiung-Chyi Shen
CYChiou-Ying Yang
Chiou-Ying Yang
Luteolin (3′,4′,5,7-tetrahydroxyflavone) is a common flavonoid in many types of plants and has several beneficial biological effects, including anti-inflammation, anti-oxidant, and anti-cancer properties. However, the detail mechanisms of luteolin in suppressing tumor invasion and metastasis are poorly understood. Here, we investigated the effects of luteolin on suppressing glioblastoma tumor cell invasion and migration activity. Under the non-cytotoxic doses (15 and 30 μM), luteolin exhibited an inhibitory effect on migration and invasion in U-87 MG and T98G glioblastoma cells. Additionally, filopodia assembly in U-87 MG cells was markedly suppressed after luteolin treatment. The treatment of luteolin also showed a decrease of Cdc42 (cell division cycle 42) protein levels and reduced PI3K/AKT activation, whereas there was no association between this decrease and phosphorylated ERK or altered transcription levels of Cdc42. Over expression of constitutive Cdc42 (Q61L) using transient transfection in U-87 MG cells induced a partial cell migration, but did not affected the degradation of the protein levels of Cdc42 after luteolin treatment. Moreover, inhibition of the proteaosome pathway by MG132 caused a significant recovery in the migration ability of U-87 MG cells and augmented the Cdc42 protein levels after luteolin treatment, suggesting that pharmacological inhibition of migration via luteolin treatment is likely to preferentially facilitate the protein degradation of Cdc42. Taken together, the study demonstrated that flavonoids of luteolin prevent the migration of glioblastoma cells by affecting PI3K/AKT activation, modulating the protein expression of Cdc42 and facilitating their degradation via the proteaosome pathway.

1 February 2009 in Vaccine
Verified
Journal Article
Closed access
HCHsin-Wei Chen
Hsin-Wei Chen
SLShih-Jen Liu
Shih-Jen Liu
HLHsueh-Hung Liu
Hsueh-Hung Liu
YKYan Kwok
Yan Kwok
CLChang-Ling Lin
Chang-Ling Lin
CLChih-Hsiang Leng
Chih-Hsiang Leng

10 April 2014 in Immunology
Verified
Journal Article
Closed access
PDF file
JSJacqueline Sharon
Jacqueline Sharon
MRMichael J. Rynkiewicz
Michael J. Rynkiewicz
ZLZhaohua Lu
Zhaohua Lu
CYChiou-Ying Yang
Chiou-Ying Yang